Option offered to under-30s after UK records 79 cases of rare blood clots out of 20m jabs administered
- Jab fears may play into hands of anti-vaxxers
- Coronavirus – latest UK updates
- See all our coronavirus coverage
Experts warned of damage to confidence in the UK’s vaccine programme after 10 million adults under 30 were told they will be offered an alternative to the Oxford/AstraZeneca jab following concerns over rare blood clots.
Healthy 18- to 29-year-olds who are not at high risk of Covid should have the option of a different jab if one is available in their area, the government’s joint committee on vaccines and immunisation (JCVI) said, weeks after some European countries suspended the use of Oxford/AstraZeneca jabs in younger people.Continue reading...